Box Office Poison

The Kiss of Death for Bankability

Box Office Poison is a harsh but influential label used within the film industry to describe a star who, despite their fame, is considered unbankable. This status is typically assigned to an actor after they have starred in a string of films that were commercial failures. The term implies that the actor’s name on a movie poster no longer guarantees an audience and may, in fact, be a detriment to the film’s financial prospects. The core issue is one of economics: the actor’s high salary is no longer justified by the box office revenue their films are generating.

Historical Context and the Vicious Cycle

The term was famously solidified in a 1938 article by an independent theater owners’ group that listed some of the biggest stars of the day—including Joan Crawford, Katharine Hepburn, Marlene Dietrich, and Fred Astaire—as “Box Office Poison.” The article argued that these stars’ recent films had consistently lost money for theaters.

Once an actor is labeled as box office poison, they can become trapped in a vicious cycle. Studios become reluctant to cast them in big-budget, A-list projects. This forces the actor to take on roles in smaller, riskier, or lower-quality films, which are themselves less likely to be commercially successful. The failure of these projects then further reinforces the perception that the actor is no longer a draw, making it even harder to get hired for a major film.

The Possibility of a Comeback

This label is not necessarily a career death sentence. Film history is filled with remarkable comeback stories. An actor can shed the “box office poison” label with a single, career-redefining role in a critically acclaimed or massively successful film. Katharine Hepburn famously orchestrated her own comeback by acquiring the rights to the play The Philadelphia Story and turning it into a smash-hit film. A more modern example is John Travolta, whose career was revitalized by his iconic role in Quentin Tarantino’s Pulp Fiction (1994) after a period of commercial decline.